Med-tech startup Metavention raises $65M, names new CEO

New Enterprise Associates led the investment in Metavention, which is developing technology to treat Type 2 diabetes.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.